ICP-MS raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-07-29 and is reviewed periodically as new material appears.
Solid material is typically kept as a lyophilised powder in a sealed, light-protected container at minus 20 degrees Celsius, with desiccant where humidity is high. Working solutions are often prepared fresh, aliquoted and frozen to avoid repeated freeze-thaw cycles. Glassware and buffers are checked for trace metal contamination, since other transition metals can displace copper. Records of lot number, reconstitution date and storage temperature help trace unexpected colour changes. Blue colour itself is not a reliable purity test, because partly degraded solutions can remain visibly coloured.
Identity and purity are normally checked by reversed-phase high-performance liquid chromatography, often coupled to mass spectrometry. The peptide absorbs in the ultraviolet region, and the copper complex also shows a broad visible absorption band that can be followed spectroscopically. Copper content is measured separately, for example by inductively coupled plasma mass spectrometry or atomic absorption spectroscopy, because the peptide assay alone does not confirm how much metal is bound. Purity figures therefore need a stated basis: peptide peak area, copper content, or both.
Aqueous GHK-Cu solutions are less stable than the dry powder. Light, dissolved oxygen and elevated temperature all accelerate loss of the intact complex, and the main observable changes are fading of the blue colour and the appearance of peptide fragments. Acidic conditions protonate the histidine imidazole and weaken copper binding, while strongly alkaline conditions promote hydrolysis of the peptide backbone. Because several degradation routes operate at once, a single shelf-life figure does not describe all storage conditions.
Published work on GHK-Cu concentrates largely on cell culture systems rather than whole organisms. Frequently used endpoints include collagen synthesis, expression of matrix metalloproteinases, and migration of fibroblasts. Some reports describe antioxidant behavior, while others stress delivery of copper into cells. These mechanisms are proposed rather than demonstrated, and the relative weight of each pathway is unclear. Human trials are few and generally small, so laboratory findings should not be read as confirmed clinical results.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The peptide backbone consists of glycine, histidine, and lysine joined in that order. Copper is held through the imidazole nitrogen of histidine and the alpha-amino group at the N-terminus, which together produce a square-planar arrangement around the metal center. The solid appears blue to violet, a color that originates from d-d electronic transitions within the copper coordination sphere. The complex is indexed under CAS number 89030-95-5.
| Property | Value | Notes |
|---|---|---|
| Powder storage | Minus 20 degrees Celsius, dry, dark | Desiccant used where humidity is high |
| Solution storage | Frozen, single-use aliquots | Repeated freeze-thaw cycles increase breakdown |
| Light sensitivity | Loss of intact complex under prolonged light | Amber or opaque containers reduce exposure |
| Copper assay | ICP-MS or atomic absorption spectroscopy | Reports total copper, not the fraction bound to peptide |
| Purity assay | Reversed-phase HPLC with UV or MS detection | States whether purity refers to peptide peaks or to metal content |
Copper content is measured separately, since a peptide assay alone does not report the metal-to-peptide ratio. Elemental techniques such as inductively coupled plasma optical emission spectroscopy quantify copper after acid digestion of the sample. The result is compared with the theoretical value for a one-to-one complex, and a shortfall indicates free peptide or partial dissociation. Suppliers differ in how they state purity, as some quote peptide content and others quote the whole complex. A defined stoichiometry therefore requires both a peptide assay and a copper assay.
Solid GHK-Cu is usually supplied as a lyophilized powder and is kept cold and dry. Moisture, light, and repeated temperature cycling shorten its useful life in the laboratory. In aqueous solution the complex undergoes slow hydrolysis of the peptide backbone and gradual loss of coordinated copper. Buffers containing strong chelators, such as EDTA, compete for the metal and strip it from the peptide. Working solutions are therefore prepared shortly before use, and leftover liquid is not returned to the stock container.
Commercial products list GHK-Cu as copper tripeptide-1, a cosmetic ingredient. Formulators value its blue color and water solubility, which allow incorporation into serums, creams, and masks. Regulatory treatment varies: in the United States it appears in cosmetics, while some jurisdictions classify certain claims as drug-like. The compound is not an approved drug for any indication. Studies continue to examine its effects on skin, hair, and wound repair, but dosage, delivery, and long-term safety questions remain open.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine and copper(II). The peptide sequence consists of glycine, histidine, and lysine, and its imidazole and amino groups provide binding sites for the metal ion. In the complex, copper is held through nitrogen donors from the histidine side chain, the N-terminal amine, and deprotonated amide nitrogens. The resulting compound is intensely blue and water-soluble. It occurs naturally in human plasma, saliva, and urine at low concentrations.
The peptide was first isolated from human albumin in 1973 by Loren Pickart, who later described its copper-binding behavior. Early work linked the complex to wound healing and tissue remodeling. Plasma levels of GHK decline with age, a pattern that stimulated interest in topical and supplemental applications. Researchers have reported that the tripeptide influences collagen synthesis, antioxidant defense, and inflammatory signaling in cell and animal models. Human clinical evidence remains limited and often relies on small studies.
Analytical verification typically combines reversed-phase high-performance liquid chromatography with ultraviolet-visible detection. The copper complex absorbs visible light near 600–630 nm, giving a characteristic blue signal. Mass spectrometry confirms molecular mass and can detect free peptide or mismatched copper stoichiometry. Copper content is often measured independently by inductively coupled plasma mass spectrometry or atomic absorption spectroscopy. Purity, counterion identity, and residual solvents are additional quality-control parameters that methods may address.
Solid GHK-Cu is generally stored as a dry powder under frozen conditions to limit degradation. The peptide bond can hydrolyze, and the copper center can be displaced by strong chelators such as EDTA. Aqueous solutions are less stable than the solid and may lose color or form precipitates over time. Temperature, pH, and oxygen exposure are the main variables that affect shelf life. Neutral to slightly acidic conditions tend to preserve the complex better than strongly alkaline media.
Routine handling calls for minimizing freeze-thaw cycles and preparing solutions shortly before use. Glass or inert plastic containers reduce adsorption and metal leaching. Working stocks are often kept at 2–8 °C for short periods, while long-term reference material stays at −20 °C or below. Light protection is prudent because prolonged exposure may accelerate oxidation of the peptide. Documentation of lot number, concentration, and preparation date supports reproducibility in laboratory work.
Several names circulate for the same material, which complicates literature searches. Cosmetic ingredient lists often use copper tripeptide-1, while older biochemistry papers use glycyl-L-histidyl-lysine or its abbreviation GHK. The copper complex is sometimes written as GHK-Cu(II) to make the oxidation state explicit. Terminology is not fully standardized, so matching a compound across sources requires attention to the exact sequence, the counterion, and the stated copper content. Reviews that compare studies must account for these naming differences before drawing conclusions.
GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, a short sequence of three amino acids. The peptide was first isolated from human plasma in 1973 during research on factors that influence tissue repair in liver. Its ability to bind copper ions became a central point of interest because the metal changes the peptide's chemistry and its behaviour in laboratory systems. Today the compound appears in cosmetic formulations, cell-culture studies, and biochemistry literature under several names.
The peptide sequence places a histidine in the middle, and this residue dominates metal binding. Copper(II) coordinates through the imidazole nitrogen of histidine and the terminal amino group, forming a stable chelate ring system. Loss of the copper ion leaves the free tripeptide, which has different solubility and reactivity. This structural detail matters because assays that measure only the peptide backbone can miss whether copper is still bound to it.
=== Remediation === Algae has shown selectivity for strontium in studies, where most plants used in bioremediation have not shown selectivity between calcium and strontium, often becoming saturated with calcium, which is greater in quantity and also present in nuclear waste. Researchers have looked at the bioaccumulation of strontium by Scenedesmus spinosus (algae) in simulated wastewater. The study claims a highly selective biosorption capacity for strontium of S. spinosus, suggesting that it may be appropriate for use in treating nuclear wastewater. A study of the pond alga Closterium moniliferum using non-radioactive strontium found that varying the ratio of barium to strontium in water improved strontium selectivity.
=== Casting === Bosworth was paid $500,000 to star as undercover cop Joe Huff, This was his first non-football role, and he trained extensively with acting coach Harold Guskin. Wichard, who was noted for his hyperbolic statements, claimed that some of the lessons lasted up to 20 hours. Michelle Johnson signed on to play Huff's wife, while Punky Brewster's Ami Foster was cast as his troubled younger sister, but creative changes led to both characters being cut during production. Lance Henriksen and Arabella Holzbog had appeared together shortly before in The Last Samurai. Henriksen had also co-starred with William Forsythe in the 1985 biker movie Savage Dawn. The lead actors trained with biker and stuntman Greg "Magic" Schwartz. Bosworth and Henriksen, both motorcycle enthusiasts, personally oversaw the customization of their bikes for the film. Henriksen's was painted by Jane Pollack, a member of the film's art department, who would later become his wife although the two did not connect on this shoot. Henriksen was unconvinced by the background players selected to portray his "Brotherhood", and personally toured Gulf Coast bike shops to recruit some that looked more legitimate. However, when a reporter mistakenly stated that Henriksen was a real-life member of the Bandidos MC gang, a rebuttal had to be quickly put out to avoid tensions with any of them.
== The TRAIL receptors as a drug target == In clinical trials only a small proportion of cancer patients responded to various drugs that targeted TRAIL death receptors. Many cancer cell lines develop resistance to TRAIL and limits the efficacy of TRAIL-based therapies.
=== Neurodegenerative disorders === The release of glutamate by system Xc- may lead to excitotoxicity, which is initiated by extrasynaptic NMDA receptors and can cause neuronal death. It has been observed that glutamate released from microglia leads to oligodendrocyte death in culture and in the rat optic nerve. However, an increase in system Xc- activity also has a protective effect by increasing levels of glutathione. Oxidative stress has been shown to lead to an increase in system Xc- expression, therefore there must be a balance between the positive protective effects of increased glutathione levels and the negative excitotoxicity effects of increased extrasynaptic glutamate levels.
== Status at birth == As with many other European monarchs during World War II, King Peter II left his country to establish a government-in-exile. He left Yugoslavia in April 1941 and arrived in London in June 1941. The Royal Yugoslav Armed Forces capitulated in 18 April. After the Tehran Conference, the Allies shifted support from royalist Chetniks to communist-led Partisans. Commenting on the event and what happened to his father, Crown Prince Alexander said, "He [Peter II] was too straight. He could not believe that his allies – the mighty American democracy and his relatives and friends in London – could do him in. But that's precisely what happened". In June 1944, Ivan Šubašić, the Royalist prime minister, and Josip Broz Tito, the Communist Partisan leader, signed an agreement that was an attempt to merge the royal government and communist movement. On 29 November 1943, AVNOJ (formed by the Partisans) declared themselves the sovereign communist government of Yugoslavia and announced that they would take away all legal rights from the Royal government. On 10 August 1945, less than a month after Alexander's birth, AVNOJ named the country Democratic Federal Yugoslavia. On 29 November 1945, the country was declared a communist republic and changed its name to People's Federal Republic of Yugoslavia. In 1947, all members of Alexander's family except for his granduncle Prince George were deprived of their Yugoslav citizenship and their property was confiscated.
Sources: en.wikipedia.org
Glyn Ford and Jonathan Simnett, Silver from the Sea, September/October 1982, Volume 33, Number 5, Saudi Aramco World Archived 2006-11-12 at the Wayback Machine Accessed 17 October 2005 Ballard, Robert D., 2000, The Eternal Darkness, Princeton University Press. Csotonyi, J. T.; Stackebrandt, E.; Yurkov, V. (4 July 2006). "Anaerobic Respiration on Tellurate and Other Metalloids in Bacteria from Hydrothermal Vent Fields in the Eastern Pacific Ocean". Applied and Environmental Microbiology. 72 (7): 4950–4956. Bibcode:2006ApEnM..72.4950C. doi:10.1128/AEM.00223-06. PMC 1489322. PMID 16820492. Koschinsky, Andrea; Garbe-Schönberg, Dieter; Sander, Sylvia; Schmidt, Katja; Gennerich, Hans-Hermann; Strauss, Harald (2008). "Hydrothermal venting at pressure-temperature conditions above the critical point of seawater, 5°S on the Mid-Atlantic Ridge". Geology. 36 (8): 615. Bibcode:2008Geo....36..615K. doi:10.1130/G24726A.1. Catherine Brahic (4 August 2008). "Found: The hottest water on Earth". New Scientist. Retrieved 18 June 2010.
Casa Esperanza Montessori School (K-8) Endeavor Charter School (K-8) Exploris Middle School (1–8) Hope Elementary School (K-5) Longleaf School of the Arts (9–12) Magellan Charter School (3–8) PreEminent Charter School (K-8) Quest Academy (K-8) Raleigh Charter High School (9–12) Torchlight Academy (K-6) Woods Charter School (K-12)
==== MeSH D06.472.317 – gastrointestinal hormones ==== MeSH D06.472.317.152 – cholecystokinin MeSH D06.472.317.152.700 – sincalide MeSH D06.472.317.350 – epidermal growth factor MeSH D06.472.317.400 – gastric inhibitory polypeptide MeSH D06.472.317.410 – gastrin-releasing peptide MeSH D06.472.317.413 – gastrins MeSH D06.472.317.413.593 – pentagastrin MeSH D06.472.317.413.800 – tetragastrin MeSH D06.472.317.469 – glucagon precursors MeSH D06.472.317.469.500 – enteroglucagons MeSH D06.472.317.469.500.500 – glucagon-like peptide 1 MeSH D06.472.317.525 – motilin MeSH D06.472.317.662 – peptide yy MeSH D06.472.317.800 – secretin MeSH D06.472.317.950 – vasoactive intestinal peptide
=== Numbers of new drugs === Under the ODA and EU legislation, many orphan drugs have been developed, including drugs to treat glioma, multiple myeloma, cystic fibrosis, phenylketonuria, snake venom poisoning, and idiopathic thrombocytopenic purpura. The Pharmaceutical Executive opines that the "ODA is nearly universally acknowledged to be a success". Before the US Congress enacted the ODA in 1983, only 38 drugs were approved in the US specifically to treat orphan diseases. In the US, from January 1983 to June 2004, 249 orphan drugs received marketing authorization and 1,129 received different orphan drug designations, compared to fewer than ten such products in the decade prior to 1983. From 1983 until May 2010, the FDA approved 353 orphan drugs and granted orphan designations to 2,116 compounds. As of 2010, 200 of the roughly 7,000 officially designated orphan diseases have become treatable. Critics have questioned whether orphan drug legislation was the real cause of this increase, claiming that many of the new drugs were for disorders which were already being researched anyway, and would have had drugs developed regardless of the legislation, and whether the ODA has truly stimulated the production of non-profitable drugs; the act also has been criticised for allowing some pharmaceutical companies to make a large profit off drugs which have a small market but sell for a high price.
== tRNAome == Transfer RNA (tRNA) is an important part of Translation. tRNAs read the mRNA, bringing the amino acids the ribosome assembles into a polypeptide. As such, the abundances and types of tRNAs hava a large effect on the speed of protein synthesis. tRNAs can be very similar to other tRNAs, with some tRNA species only differing by a single nucleotide. This, coupled with similar secondary and tertiary structures, makes separating different tRNA species difficult.
Sources: en.wikipedia.org
The colour depends on copper held in a specific coordination environment. When the complex dissociates or the peptide is cleaved, that environment changes and the visible absorption weakens.
Frozen solutions are generally less stable than dry powder, and repeated thawing accelerates breakdown. Storage temperature, concentration and buffer composition all shift the rate, so no single figure applies to every preparation.
Chromatography separates and quantifies peptide species but does not report metal content. A separate elemental measurement is needed to show how much copper is present.
It is the copper complex of the tripeptide glycyl-L-histidyl-lysine. The metal ion is held by the histidine imidazole group and the peptide N-terminus. Most research on it concerns skin and wound models.